Pleasantville, NY, United States of America

Michelle LaFond

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Michelle LaFond

Introduction

Michelle LaFond is an accomplished inventor based in Pleasantville, NY (US). She has made significant contributions to the field of biotechnology, particularly in the area of protein production. With a total of 2 patents, her work has the potential to impact various industries, including pharmaceuticals and biologics.

Latest Patents

One of her latest patents is titled "Metabolically optimized cell culture - Improved methods for large scale production of proteins and/or polypeptides in cell culture." This innovative method focuses on culturing cells that have undergone metabolic shifts. By utilizing this approach, high levels of protein or polypeptide production can be achieved while minimizing the accumulation of unwanted metabolic waste, such as lactate. The proteins and polypeptides produced through this method can be effectively used in the preparation of pharmaceutical, immunogenic, or other commercial biologic compositions, including antibodies.

Career Highlights

Michelle LaFond is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at Regeneron has positioned her as a key player in the biotechnology sector, contributing to the company's mission of delivering innovative medicines.

Collaborations

Some of her notable coworkers include Shawn M Lawrence and Ann Kim. Their collaborative efforts have further enhanced the research environment at Regeneron, fostering innovation and creativity in their projects.

Conclusion

Michelle LaFond's contributions to the field of biotechnology through her patents and work at Regeneron Pharmaceuticals, Inc. highlight her role as a leading inventor. Her innovative methods for protein production are paving the way for advancements in pharmaceuticals and biologics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…